List of Tables
Table 1. Nucleic Acid–Based Diagnostic Market Trends
Table 2. Nucleic Acid–Based Diagnostic Market Drivers & Opportunity
Table 3. Nucleic Acid–Based Diagnostic Market Challenges
Table 4. Nucleic Acid–Based Diagnostic Market Restraints
Table 5. Global Nucleic Acid–Based Diagnostic Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Nucleic Acid–Based Diagnostic Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Nucleic Acid–Based Diagnostic Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Nucleic Acid–Based Diagnostic Product Type
Table 9. Key Companies Time to Begin Mass Production of Nucleic Acid–Based Diagnostic
Table 10. Global Nucleic Acid–Based Diagnostic Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid–Based Diagnostic as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Nucleic Acid–Based Diagnostic Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Nucleic Acid–Based Diagnostic Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Nucleic Acid–Based Diagnostic Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Nucleic Acid–Based Diagnostic Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Nucleic Acid–Based Diagnostic Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Nucleic Acid–Based Diagnostic Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Nucleic Acid–Based Diagnostic Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Nucleic Acid–Based Diagnostic Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Nucleic Acid–Based Diagnostic Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Nucleic Acid–Based Diagnostic Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Nucleic Acid–Based Diagnostic Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Nucleic Acid–Based Diagnostic Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Nucleic Acid–Based Diagnostic Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Nucleic Acid–Based Diagnostic Sales Value by Region (2019-2024) & (%)
Table 27. Global Nucleic Acid–Based Diagnostic Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Nucleic Acid–Based Diagnostic Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Nucleic Acid–Based Diagnostic Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Nucleic Acid–Based Diagnostic Sales Value, (2025-2030) & (US$ Million)
Table 31. Agilent Technologies Basic Information List
Table 32. Agilent Technologies Description and Business Overview
Table 33. Agilent Technologies Nucleic Acid–Based Diagnostic Products, Services and Solutions
Table 34. Revenue (US$ Million) in Nucleic Acid–Based Diagnostic Business of Agilent Technologies (2019-2024)
Table 35. Agilent Technologies Recent Developments
Table 36. Danaher Corporation Basic Information List
Table 37. Danaher Corporation Description and Business Overview
Table 38. Danaher Corporation Nucleic Acid–Based Diagnostic Products, Services and Solutions
Table 39. Revenue (US$ Million) in Nucleic Acid–Based Diagnostic Business of Danaher Corporation (2019-2024)
Table 40. Danaher Corporation Recent Developments
Table 41. Abbott Laboratories Basic Information List
Table 42. Abbott Laboratories Description and Business Overview
Table 43. Abbott Laboratories Nucleic Acid–Based Diagnostic Products, Services and Solutions
Table 44. Revenue (US$ Million) in Nucleic Acid–Based Diagnostic Business of Abbott Laboratories (2019-2024)
Table 45. Abbott Laboratories Recent Developments
Table 46. BD Basic Information List
Table 47. BD Description and Business Overview
Table 48. BD Nucleic Acid–Based Diagnostic Products, Services and Solutions
Table 49. Revenue (US$ Million) in Nucleic Acid–Based Diagnostic Business of BD (2019-2024)
Table 50. BD Recent Developments
Table 51. Bio-Rad Laboratories Basic Information List
Table 52. Bio-Rad Laboratories Description and Business Overview
Table 53. Bio-Rad Laboratories Nucleic Acid–Based Diagnostic Products, Services and Solutions
Table 54. Revenue (US$ Million) in Nucleic Acid–Based Diagnostic Business of Bio-Rad Laboratories (2019-2024)
Table 55. Bio-Rad Laboratories Recent Developments
Table 56. Roche Basic Information List
Table 57. Roche Description and Business Overview
Table 58. Roche Nucleic Acid–Based Diagnostic Products, Services and Solutions
Table 59. Revenue (US$ Million) in Nucleic Acid–Based Diagnostic Business of Roche (2019-2024)
Table 60. Roche Recent Developments
Table 61. Illumina, Inc Basic Information List
Table 62. Illumina, Inc Description and Business Overview
Table 63. Illumina, Inc Nucleic Acid–Based Diagnostic Products, Services and Solutions
Table 64. Revenue (US$ Million) in Nucleic Acid–Based Diagnostic Business of Illumina, Inc (2019-2024)
Table 65. Illumina, Inc Recent Developments
Table 66. Thermo Fisher Scientific Inc. Basic Information List
Table 67. Thermo Fisher Scientific Inc. Description and Business Overview
Table 68. Thermo Fisher Scientific Inc. Nucleic Acid–Based Diagnostic Products, Services and Solutions
Table 69. Revenue (US$ Million) in Nucleic Acid–Based Diagnostic Business of Thermo Fisher Scientific Inc. (2019-2024)
Table 70. Thermo Fisher Scientific Inc. Recent Developments
Table 71. Merck KGaA Basic Information List
Table 72. Merck KGaA Description and Business Overview
Table 73. Merck KGaA Nucleic Acid–Based Diagnostic Products, Services and Solutions
Table 74. Revenue (US$ Million) in Nucleic Acid–Based Diagnostic Business of Merck KGaA (2019-2024)
Table 75. Merck KGaA Recent Developments
Table 76. Qiagen Basic Information List
Table 77. Qiagen Description and Business Overview
Table 78. Qiagen Nucleic Acid–Based Diagnostic Products, Services and Solutions
Table 79. Revenue (US$ Million) in Nucleic Acid–Based Diagnostic Business of Qiagen (2019-2024)
Table 80. Qiagen Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Nucleic Acid–Based Diagnostic Downstream Customers
Table 84. Nucleic Acid–Based Diagnostic Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Nucleic Acid–Based Diagnostic Product Picture
Figure 2. Global Nucleic Acid–Based Diagnostic Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Nucleic Acid–Based Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 4. Nucleic Acid–Based Diagnostic Report Years Considered
Figure 5. Global Nucleic Acid–Based Diagnostic Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Nucleic Acid–Based Diagnostic Revenue in 2023
Figure 7. Nucleic Acid–Based Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Nucleic Acid Molecular Hybridization Picture
Figure 9. Polymerase Chain Reaction Picture
Figure 10. Thermostatic Amplification Picture
Figure 11. Gene Sequencing Picture
Figure 12. Biochip Technology Picture
Figure 13. Global Nucleic Acid–Based Diagnostic Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Nucleic Acid–Based Diagnostic Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Clinical Laboratory
Figure 17. Product Picture of Research Institutions
Figure 18. Product Picture of Clinic
Figure 19. Product Picture of Other
Figure 20. Global Nucleic Acid–Based Diagnostic Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Nucleic Acid–Based Diagnostic Sales Value Market Share by Application, 2023 & 2030
Figure 22. North America Nucleic Acid–Based Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Nucleic Acid–Based Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 24. Europe Nucleic Acid–Based Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Nucleic Acid–Based Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 26. Asia Pacific Nucleic Acid–Based Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia Pacific Nucleic Acid–Based Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 28. South America Nucleic Acid–Based Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 29. South America Nucleic Acid–Based Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Nucleic Acid–Based Diagnostic Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Nucleic Acid–Based Diagnostic Sales Value by Country (%), 2023 VS 2030
Figure 32. Key Countries/Regions Nucleic Acid–Based Diagnostic Sales Value (%), (2019-2030)
Figure 33. United States Nucleic Acid–Based Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 34. United States Nucleic Acid–Based Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 35. United States Nucleic Acid–Based Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 36. Europe Nucleic Acid–Based Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 37. Europe Nucleic Acid–Based Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 38. Europe Nucleic Acid–Based Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 39. China Nucleic Acid–Based Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 40. China Nucleic Acid–Based Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 41. China Nucleic Acid–Based Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 42. Japan Nucleic Acid–Based Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 43. Japan Nucleic Acid–Based Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 44. Japan Nucleic Acid–Based Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 45. South Korea Nucleic Acid–Based Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 46. South Korea Nucleic Acid–Based Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 47. South Korea Nucleic Acid–Based Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 48. Southeast Asia Nucleic Acid–Based Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Nucleic Acid–Based Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 50. Southeast Asia Nucleic Acid–Based Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 51. India Nucleic Acid–Based Diagnostic Sales Value, (2019-2030) & (US$ Million)
Figure 52. India Nucleic Acid–Based Diagnostic Sales Value by Type (%), 2023 VS 2030
Figure 53. India Nucleic Acid–Based Diagnostic Sales Value by Application (%), 2023 VS 2030
Figure 54. Nucleic Acid–Based Diagnostic Industrial Chain
Figure 55. Nucleic Acid–Based Diagnostic Manufacturing Cost Structure
Figure 56. Channels of Distribution (Direct Sales, and Distribution)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
